Georgios Vamvouras

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Explainable MRI radiomics identifies a PTEN-associated imaging phenotype in adult gliomas.

Explainable MRI radiomics identifies a PTEN-associated imaging phenotype in adult gliomas.

Journal: Frontiers in oncology
Published: June 05, 2026

Calibrated and explainable multiparametric MRI radiomics for differentiating tumor positive disease from treatment-related changes in glioblastoma.

Calibrated and explainable multiparametric MRI radiomics for differentiating tumor positive disease from treatment-related changes in glioblastoma.

Journal: Frontiers in oncology
Published: May 25, 2026

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma.

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma.

Journal: Frontiers in oncology
Published: May 09, 2026

ASLNet: an explainable deep learning framework for glioma grading and survival prediction.

ASLNet: an explainable deep learning framework for glioma grading and survival prediction.

Journal: Frontiers in oncology
Published: February 26, 2026

Modality-level attribution and redundancy-aware radiomics for MRI-based differentiation of melanoma and NSCLC brain metastases.

Modality-level attribution and redundancy-aware radiomics for MRI-based differentiation of melanoma and NSCLC brain metastases.

Journal: Frontiers in oncology
Published: February 23, 2026

Explainable, modality-adaptive radiomics for MGMT methylation prediction in high-grade glioma: a decision-curve analysis study.

Explainable, modality-adaptive radiomics for MGMT methylation prediction in high-grade glioma: a decision-curve analysis study.

Journal: Frontiers in oncology
Published: October 23, 2025

Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer's Disease.

Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer's Disease.

Journal: Biomedicines
Published: September 28, 2025

Interpretable Machine Learning for Risk Stratification of Hippocampal Atrophy in Alzheimer's Disease Using CSF Erythrocyte Load and Clinical Data.

Interpretable Machine Learning for Risk Stratification of Hippocampal Atrophy in Alzheimer's Disease Using CSF Erythrocyte Load and Clinical Data.

Journal: Biomedicines
Published: September 21, 2025

From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer's Disease.

From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer's Disease.

Journal: Journal of clinical medicine
Published: September 12, 2025

From Lesion to Decision: AI for ARIA Detection and Predictive Imaging in Alzheimer's Disease.

From Lesion to Decision: AI for ARIA Detection and Predictive Imaging in Alzheimer's Disease.

Journal: Biomedicines
Published: September 07, 2025

Cerebrospinal Fluid Erythrocyte Burden Amplifies the Impact of PTAU on Entorhinal Degeneration in Alzheimer's Disease.

Cerebrospinal Fluid Erythrocyte Burden Amplifies the Impact of PTAU on Entorhinal Degeneration in Alzheimer's Disease.

Journal: Biomolecules
Published: August 18, 2025

Erythrocyte Load in Cerebrospinal Fluid Linked with Hippocampal Atrophy in Alzheimer's Disease.

Erythrocyte Load in Cerebrospinal Fluid Linked with Hippocampal Atrophy in Alzheimer's Disease.

Journal: Journal of clinical medicine
Published: May 22, 2025
Showing 1-12 of 12

Last Updated: 09/26/2026